Patent ID: 8032306

Claim:
One or more computer-storage media having computer-executable instructions for performing a method for processing patient vital signs during blood product administration in a computerized healthcare environment, the method comprising: identifying a blood product to be administered to a patient by receiving, at a remote computer at the patient's bedside, a blood product identifier identifying the blood product to be administered to the patient; identifying the patient by receiving, at the remote computer at the patient's bedside, a patient identifier identifying the patient; communicating the blood product identifier and the patient identifier to a blood bank database to maintain a record of the blood product administration; communicating a start time of the blood product administration to the blood bank database; receiving vital signs, at the remote computer at the patient's beside, at a first time instance for the patient identified at the patient's bedside during administration of the blood product identified at the patient's bedside by a healthcare provider; determining whether the vital signs at the first time instance for the patient during the blood product administration are within an acceptable range by comparing the vital signs received at the remote computer at the patient's beside with an acceptable range of vital signs during blood product administration; upon determining that the vital signs at the first time instance for the patient during the blood product administration are within the acceptable range, determining whether the blood product administration is complete; upon determining that the blood product administration is not complete, notifying the blood bank database that the blood product administration is not complete such that the blood bank database includes accurate information regarding blood product administration status and receiving, at the remote computer at the patient's beside, vital signs at a second time instance for the patient during the blood product administration; determining whether the vital signs at the second time instance for the patient obtained during the blood product administration are within the acceptable range by comparing the vital signs at the second time instance received from the remote computer at the patient's beside with the acceptable range of vital signs during blood product administration; upon a determination that the vital signs at the second time instance are not within the acceptable range, displaying a notification at the bedside of the patient to the healthcare provider currently administering the blood product to the patient; and automatically, without user intervention, documenting in a patient database the vital signs for the patient and whether the vital signs for the patient are within the acceptable range.